Prelude Therapeutics Incorporated
PRLD
$4.66
$0.020.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 87.81% | -24.94% | -26.10% | -25.85% | -13.03% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -26.53% | -7.84% | 9.94% | 45.94% | -17.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 81.20% | -24.12% | -24.93% | -24.65% | -13.10% |
|
|
|||||
| Total Current Assets | 81.20% | -24.12% | -24.93% | -24.65% | -13.10% |
| Net Property, Plant & Equipment | -2.42% | -2.38% | -2.35% | -2.15% | -2.52% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -19.48% | 0.00% | 0.00% | -6.63% |
| Total Assets | 49.14% | -17.55% | -18.65% | -19.52% | -11.01% |
|
|
|||||
| Total Accounts Payable | 57.24% | -48.95% | -14.90% | -24.59% | 30.59% |
| Total Accrued Expenses | -3.33% | -3.29% | 16.66% | -26.53% | 12.99% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.62% | 0.59% | 2.19% | -1.74% | -0.88% |
| Total Finance Division Other Current Liabilities | 3,503.22% | 11.85% | 23.71% | -9.73% | -3.75% |
| Total Other Current Liabilities | 3,503.22% | 11.85% | 23.71% | -9.73% | -3.75% |
| Total Current Liabilities | 191.34% | -13.00% | 5.67% | -22.83% | 15.38% |
|
|
|||||
| Total Current Liabilities | 191.34% | -13.00% | 5.67% | -22.83% | 15.38% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.54% | -0.52% | -0.40% | -0.38% | -0.56% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 59.75% | -2.09% | -2.05% | -2.01% | -2.00% |
| Total Liabilities | 100.65% | -7.32% | 2.62% | -13.56% | 8.01% |
|
|
|||||
| Common Stock & APIC | 3.66% | 0.33% | 0.54% | 0.54% | 0.55% |
| Retained Earnings | -2.47% | -3.05% | -5.07% | -5.50% | -5.18% |
| Treasury Stock & Other | 300.00% | 300.00% | -108.33% | -65.71% | -79.04% |
| Total Common Equity | 17.26% | -22.82% | -26.50% | -21.51% | -15.96% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.26% | -22.82% | -26.50% | -21.51% | -15.96% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.26% | -22.82% | -26.50% | -21.51% | -15.96% |
|
|
|||||